美国移民拘留中的物质使用障碍和物质使用相关死亡率 (2018-2025)
Journal of addiction medicine
|November 3, 2025
概括
美国移民和海关执法局 (ICE) 拘留中的死亡显示,在物质使用障碍 (SUD) 识别和治疗方面可能存在差距. 未经治疗的SUD并发症和延迟的应急响应导致死亡,突出了改善方案的需要.
科学领域:
- 公共卫生 公共卫生
- 法医医学 法医医学
- 成 药物 药物 药物 药物
背景情况:
- 药物使用障碍 (SUDs) 对健康构成重大风险.
- 移民拘留机构可能会给SUD管理带来独特的挑战.
研究的目的:
- 评估记录的物质使用指标和SUDs在美国移民和海关执法 (ICE) 监护下的死亡中的作用.
- 为了确定在这个人群中对SUD的查,诊断和治疗的潜在差距.
主要方法:
- 从2018年4月到2025年5月,对69份公开的ICE拘留者死亡审查 (DDR) 进行了回顾性横截面审查.
- 医学许可审查员对物质使用指标,临床护理和紧急响应的分析.
- 包括人口,精神病和医疗保健准入等变量.
主要成果:
- 在27例可能有药物使用史的死亡中,没有一个有记录的SUD诊断,转诊或治疗.
- 9例死亡 (33.3%) 是由于未经治疗的物质使用并发症造成的,包括阿片类药物和酒精戒断.
- 超过一半的这些病例显示紧急响应延迟;没有记录正式能力评估.
结论:
- 在ICE拘留期间死亡的个人中,SUD的记录识别和治疗存在重大差距.
- 标准化的行为健康协议和及时的应急响应至关重要.
- 需要提高透明度,以解决移民拘留中与物质相关的风险.
相关概念视频
Substance Use Disorders Affecting Sleep
394
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
394
Stress and Mental Health
625
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
625
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Pulmonary Tuberculosis I
817
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
817
Drug Control Governance: Regulatory Bodies and Their Impact
481
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
481


